Literature DB >> 1331294

The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection.

J M Grefte1, B T van der Gun, S Schmolke, M van der Giessen, W J van Son, B Plachter, G Jahn, T H The.   

Abstract

During an active infection with human cytomegalovirus (HCMV), viral antigen is consistently present in peripheral blood leukocytes. Two monoclonal antibodies (MAbs), CMV-C10 and CMV-C11, are commonly used in the HCMV antigenaemia assay to detect these cells in the peripheral blood of patients suspected of having an active HCMV infection. We demonstrate that the viral antigen detected by these MAbs is the viral structural protein pp65 and not an immediate early antigen as previously reported. Furthermore, significantly fewer leukocytes were found to be positive with MAbs specific for immediate early antigens.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331294     DOI: 10.1099/0022-1317-73-11-2923

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  38 in total

1.  High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay.

Authors:  Lutz Von Müller; Walter Hampl; Joachim Hinz; Helga Meisel; Angela Reip; Elisabeth Engelmann; Regine Heilbronn; Barbara Gärtner; Oliver Krämer; Hermann Einsele; Holger Hebart; Tatjana Ljubicic; Jürgen Löffler; Thomas Mertens
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  Cytomegalovirus disease of the upper gastrointestinal tract in patients with rheumatic diseases: a case series and literature review.

Authors:  Takashi Ozaki; Hiroyuki Yamashita; Shunta Kaneko; Hideki Yorifuji; Hiroyuki Takahashi; Yo Ueda; Yuko Takahashi; Hiroshi Kaneko; Toshikazu Kano; Akio Mimori
Journal:  Clin Rheumatol       Date:  2013-08-14       Impact factor: 2.980

3.  The intracellular localization of human cytomegalovirus DNA in peripheral blood leukocytes during active infections by high-resolution fluorescence in situ hybridization.

Authors:  H Hackstein; H Kirchner; G Jahn; G Bein
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo.

Authors:  B W A van der Strate; J L Hillebrands; S S Lycklama à Nijeholt; L Beljaars; C A Bruggeman; M J A Van Luyn; J Rozing; T H The; D K F Meijer; G Molema; M C Harmsen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Detection of human cytomegalovirus in urine samples by cell culture, early antigen assay and polymerase chain reaction.

Authors:  A Daiminger; G Schalasta; D Betzl; G Enders
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553

6.  Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus.

Authors:  M Ohlin; B Plachter; V A Sundqvist; P G Steenbakkers; J M Middeldorp; C A Borrebaeck
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

7.  Molecular, biological, and in vivo characterization of the guinea pig cytomegalovirus (CMV) homologs of the human CMV matrix proteins pp71 (UL82) and pp65 (UL83).

Authors:  Alistair McGregor; Fenyong Liu; Mark R Schleiss
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication.

Authors:  P Dal Monte; C Bessia; A Ripalti; M P Landini; A Topilko; B Plachter; J L Virelizier; S Michelson
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter.

Authors:  H Arlt; D Lang; S Gebert; T Stamminger
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.